Withdrawn trial sought answers on race and cancer drug response
NCT ID NCT06527690
Summary
This study aimed to see if a standard drug combination for advanced prostate cancer works differently for men of different racial and ethnic backgrounds. It planned to enroll men who identified as Black, Hispanic, White, or Native American. The trial was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.